Some Insurance Companies Reconsidering Rezulin

Dec 1, 1999

Horizon Blue Cross Blue Shield of New Jersey is removing Rezulin from a preferred list of drugs covered under a minority of its health plans. In addition, Aetna U.S. Healthcare says that it also may remove the type 2 diabetes drug from its formulary by the end of the year.

According to an October 21 news wire report, Rezulin will still receive some coverage but will cost patients a higher copay under Horizon's formulary. Horizon will replace Rezulin with the type 2 drugs Actos and Avandia in its drug formulary.

"Based on the current literature, it appears that Actos and Avandia are safer," says Terry Leach, formulary director for Horizon Blue Cross in Newark.

Jennifer King, spokesperson for Aetna, says that Aetna will remove Rezulin from its formulary because it has the side effects of elevated liver enzymes which Actos and Avandia do not. According to King, Aetna members who use Rezulin without any side effects may no longer get coverage for the drug if it is removed from the formulary.

"There would always be exceptions made," says King. "Doctors could appeal if they want their patients on Rezulin."

Nationwide, Rezulin has been used by approximately 1.6 million people.

Click Here To View Or Post Comments

Categories: Diabetes, History, Medications, Type 2 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.